1-7 of 7
David V. Gold
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Advanced Pancreatic Carcinoma with 90Y-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial

Available to Purchase
Seza A. Gulec, Steven J. Cohen, Kenneth L. Pennington, Lionel S. Zuckier, Ralph J. Hauke, Heather Horne, William A. Wegener, Nick Teoh, David V. Gold, Robert M. Sharkey, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4091–4100.
https://doi.org/10.1158/1078-0432.CCR-10-2579
Published: 15 June 2011
View articletitled, Treatment of Advanced Pancreatic Carcinoma with 90Y-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial
Open the PDF for Treatment of Advanced Pancreatic Carcinoma with 90Y-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial in another window
Journal Articles

Reply to the Letter to the Editor by Bara, et al

Available to Purchase
David V. Gold
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5306–5307.
https://doi.org/10.1158/1078-0432.CCR-08-1069
Published: 12 August 2008
View articletitled, Reply to the Letter to the Editor by Bara, et al
Open the PDF for Reply to the Letter to the Editor by Bara, et al in another window
Journal Articles

PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma

Available to Purchase
David V. Gold, Zarir Karanjawala, David E. Modrak, David M. Goldenberg, Ralph H. Hruban
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (24): 7380–7387.
https://doi.org/10.1158/1078-0432.CCR-07-1488
Published: 19 December 2007
View articletitled, PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma
Open the PDF for PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma in another window
Journal Articles

CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy

Available to Purchase
Jack D. Burton, Scott Ely, Praveen K. Reddy, Rhona Stein, David V. Gold, Thomas M. Cardillo, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6606–6611.
https://doi.org/10.1158/1078-0432.CCR-04-0182
Published: 08 October 2004
View articletitled, CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy
Open the PDF for CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy in another window
Journal Articles

Improved Targeting of Pancreatic Cancer: Experimental Studies of a New Bispecific Antibody, Pretargeting Enhancement System for Immunoscintigraphy

Available to Purchase
Thomas M. Cardillo, Habibe Karacay, David M. Goldenberg, Dion Yeldell, Chien-Hsing Chang, David E. Modrak, Robert M. Sharkey, David V. Gold
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3552–3561.
https://doi.org/10.1158/1078-0432.CCR-03-0340
Published: 24 May 2004
View articletitled, Improved Targeting of Pancreatic Cancer: Experimental Studies of a New Bispecific Antibody, Pretargeting Enhancement System for Immunoscintigraphy
Open the PDF for Improved Targeting of Pancreatic Cancer: Experimental Studies of a New Bispecific Antibody, Pretargeting Enhancement System for Immunoscintigraphy in another window
Journal Articles

Low-Dose Radioimmunotherapy (90Y-PAM4) Combined with Gemcitabine for the Treatment of Experimental Pancreatic Cancer

Available to Purchase
David V. Gold, Keith Schutsky, David Modrak, Thomas M. Cardillo
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3929s–3937s.
Published: 01 September 2003
View articletitled, Low-Dose Radioimmunotherapy (90Y-PAM4) Combined with Gemcitabine for the Treatment of Experimental Pancreatic Cancer
Open the PDF for Low-Dose Radioimmunotherapy (90Y-PAM4) Combined with Gemcitabine for the Treatment of Experimental Pancreatic Cancer in another window
Journal Articles

Therapeutic Advantage of 90Yttrium- versus  131Iodine-labeled PAM4 Antibody in Experimental Pancreatic Cancer

Available to Purchase
Thomas M. Cardillo, Zhiliang Ying, David V. Gold
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 3186–3192.
Published: 01 October 2001
View articletitled, Therapeutic Advantage of 90Yttrium- versus  131Iodine-labeled PAM4 Antibody in Experimental Pancreatic Cancer
Open the PDF for Therapeutic Advantage of 90Yttrium- versus  131Iodine-labeled PAM4 Antibody in Experimental Pancreatic Cancer in another window